Apraclonidine
Also known as: Lopidine
Therapeutic Indications
Apraclonidine is indicated for:
Chronic glaucoma
Irrespective of gender only Adults (18 years old or older)
Apraclonidine is indicated for short-term adjunctive therapy of chronic glaucoma in patients on maximally tolerated medical therapy who require additional intraocular pressure (IOP) reduction to delay laser treatment or glaucoma surgery.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Ophthalmic - 3 drops in 3 divided doses daily
Contraindications
Active ingredient Apraclonidine is contraindicated in the following cases:
Monoamine oxidase inhibitors
No gender/age discrimination
Tricyclic antidepressants
No gender/age discrimination
Systemic sympathomimetics
No gender/age discrimination